SEC Form 4 · accession 0002049287-26-000003
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Baiteng Zhao
Director
Period of report
Jun 12, 2026
Accepted (ET)
Jun 15, 2026 · 5:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001422142
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.16 | Jun 12, 2026 | A | 38,040 | A | — | Jun 12, 2036 | Common Stock | 38,040 | 38,040 | D |
Explanation of responses
- F1Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2026.